Lantern Pharma (LTRN) Tops Q3 EPS by 14c

Lantern Pharma (NASDAQ: LTRN) reported Q3 EPS of ($0.42), $0.14 better than the analyst estimate of ($0.56).

For earnings history and earnings-related data on Lantern Pharma (LTRN) click here.

You May Also Be Interested In

• Kalshi in early talks for IPO - The Information
• Accenture tumbles 16% on guidance cut; announces Dragos, runZero, NetRise deals
• Getty Images strikes multi-year display deal with OpenAI for ChatGPT